Industry Reports

Genomic Health Inc (GHDX) - Financial and Strategic SWOT Analysis Review

Tuesday, Nov 22, 2016

Genomic Health Inc (Genomic Health) is a provider of genomic-based clinical laboratory services for the treatment of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, and Onco type DX prostate cancer test. It perform extensive research and development activities to optimize the treatment of urologic cancers including prostate, bladder, and kidney cancers, and additional treatment decisions in breast and colon cancers. Genomic Health develops these products using its Onco type DX platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in the US, Europe, and Asia through its subsidiaries and offices. Genomic Health is headquartered in Redwood City, California, the US.

Read More>